Login to Your Account

Let's make a deal

Partnerships galore but sector still waiting on big biotech M&A

By Peter Winter

Monday, July 17, 2017

The Biotechnology Innovation Organization (BIO) revealed that at its recent BIO International Convention (BIO 2017) in San Diego a staggering 41,400 partnering meetings were held, which represented a 16 percent increase over the BIO 2016 numbers. The BIO data reveal that companies involved in the sector rely on collaborations in order to succeed. The costs of drug development simply do not allow a company to "go it alone" anymore.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription